PROBIOTYKI A ZDROWIE - DZIŚ I JUTRO

Dominika Winiarz; Kamila Domańska; Kinga Paluch; Dorota Dorota Skrajnowska

doi:10.56782/pps.82

Published : 2017-08-21

Vol. 15 No. 10 (2017)

PROBIOTICS AND HEALTH - TODAY AND TOMORROW

Dominika Winiarz

Kamila Domańska

Kinga Paluch

Dorota Dorota Skrajnowska

DOI: https://doi.org/10.56782/pps.82

Abstract

Probiotics are being used worldwide and are increasingly gaining in popularity. Probiotics are available in foods, as dietary supplements and as drugs (capsules, tablets, pills and powders). Probiotics are microorganisms with potential health benefits. They may be used to prevent and treat antibiotic-associated diarrhea and acute infectious diarrhea. They may also be effective in relieving symptoms of irritable bowel syndrome, and in treating atopic dermatitis in children. Species commonly used include Lactobacillus sp., Bifidobacterium sp., Streptococcus thermophilus, and Saccharomyces. Probiotic strains, which are selected from wild strains, have to possess certain qualities such as: being competitive against pathogens, synthesizing appropriate metabolic products and having the ability to adhere. Probiotic strains also have to show properties that allow them to be safe to use as well as render them resistant to conditions occurring during the production processes and in the human gastrointestinal tract. Conversely, the production processes used in the preparation of probiotics have to be adjusted to maintain acceptable survival rates of bacteria. To stimulate the growth of probiotic bacteria, prebiotics are used. Synbiotics are a combination of pro- and prebiotics. Pharmabiotics are a particular kind of probiotics, modified using genetic engineering to achieve desirable traits, either functional or technological. The positive effect of probiotics on the immune system is unquestionable. However, in view of individual reports on their adverse reactions (bacterial infections, fungemia, anaphylactic symptoms), their use in some patients is contraindicated. When using probiotics, it is necessary to rely on the results of well-designed clinical trials, not on advertisements. Currently, in view of a lack of solid health and nutritional data, the use of probiotics continues to rely on health claims made by the manufacturers. The purpose of this article is to provide evidence-based up-to-date information on the use of probiotics for the treatment and/or prevention of various disorders.

Keywords:

probiotics, definition of a probiotic, health effects of the use of probiotics, safety of probiotics therapy

Similar Articles

Aleksandra Mikulska, Arkadiusz Kocur, Pharmacotherapy with high doses of methotrexate (HDMTX) in oncology – how should chemotherapy be conducted based on therapeutic drug monitoring? , Prospects in Pharmaceutical Sciences: Vol. 21 No. 4 (2023)
Zofia Suchocka, OBESITY - REASONS AND TREATMENT , Prospects in Pharmaceutical Sciences: Vol. 1 No. 1 (2003)
Agnieszka Kalicka, Natalia Tarłowska, Counterfeit and illegal medicinal products as an example of drugs that do not meet the basic quality requirements , Prospects in Pharmaceutical Sciences: Vol. 21 No. 4 (2023)
Agnieszka Sienicka, Krzysztof Kubasik, Agata Pisula, The glucagon-like peptide-1 analogues therapy in the non-diabetic patients , Prospects in Pharmaceutical Sciences: Vol. 21 No. 1 (2023)
Ewelina Flegiel, Magdalena Piotrowska, Magdalena Ptasznik, Aleksandra Baran, Justyna Lenart, Miłosz Podrażka, Joanna Mazurek, Hubert Stachowicz, Weronika Bartos, Monika Adamczyk, Review of the effects of sodium butyrate on obesity, inflammatory bowel disease, pregnancy and colorectal cancer , Prospects in Pharmaceutical Sciences: Vol. 22 No. 4 (2024)
Natalia Cichoń, Dominika Lach, Michał Bijak Bijak, Paulina Rzeźnicka, Joanna Saluk, SIMILARITIES AND DIFFERENCES IN ANTIPLATELET THERAPY IN ACUTE CORONARY SYNDROMES AND ISCHEMIC STROKE , Prospects in Pharmaceutical Sciences: Vol. 14 No. 4 (2016)
Mateusz Sobczyk, Daria Żuraw, Paulina Oleksa, Kacper Jasiński, Mikołaj Porzak, Michał Dacka, SGLT2 inhibitors and their possible use in prevention and treatment of neurological diseases , Prospects in Pharmaceutical Sciences: Vol. 22 No. 1 (2024)
Aneta Emilia Jabłońska, Krzysztof Adam Stępień, COUNTERFEITING OF MEDICINAL PRODUCTS AND THREATS ASSOCIATED WITH THEIR TAKING , Prospects in Pharmaceutical Sciences: Vol. 17 No. 11 (2019)
Seda Sultan Sağır, Baturay Sapancı, Imran Uysal, Mustafa Sevindik, A review: nutrition and oral-dental health, phytochemical content, biological activity of Salvadora persica (Miswak) , Prospects in Pharmaceutical Sciences: Vol. 22 No. 2 (2024)
Mateusz Sobczyk, Mikołaj Porzak, Daria Żuraw, Alicja Sodolska, Paulina Oleksa, Kacper Jasiński, Small intestinal bacterial overgrowth – current, novel and possible future methods of treatment and diagnosis , Prospects in Pharmaceutical Sciences: Vol. 22 No. 2 (2024)

<< < 1 2 3 4 5 6 7 8 9 10 > >>

You may also start an advanced similarity search for this article.

Details

References

Statistics

Authors

Download files

PDF (Język Polski)

Citation rules

Winiarz, D., Domańska, K., Paluch, K., & Dorota Skrajnowska, D. (2017). PROBIOTICS AND HEALTH - TODAY AND TOMORROW. Prospects in Pharmaceutical Sciences, 15(10), 86–94. https://doi.org/10.56782/pps.82

Altmetric indicators

Cited by / Share

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License.

References

Mojka K. Probiotyki, prebiotyki i synbiotyki - charakterystyka i funkcje. Probiotyki, prebiotyki i synbiotyki. Prob. Hig. Epidemiol. 2014, 95(3), 541-549.

FAO/WHO: Guidelines for the Evaluation of Probiotics in Food. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. London, Onatario,Kanada, 30 kwietnia - 1 maja 2002.

Wyszyńska A, Kobierecka P, Jagusztyn-Krynicka E K. Bakterie kwasu mlekowego (lab) jako wektory do konstrukcji szczepionek. Post. Mikrobiol. 2015, 54, (2), 141-153.

Lutyńska A, Augustynowicz E, Wiatrzyk A. Problemy stosowania suplementów diety zawierających probiotyki. Prob.. Hig. Epidemiol. 2012, 93(3), 493-498.

Nowak A, Śliżewska K, Libudzisz Z. Probiotyki - historia i mechanizmy działania. Żywność. Nauka. Technologia. Jakość. 2010, 4, 5-19.

Szajewska H. Probiotyki w Polsce - kiedy, jakie i dlaczego? Gastroenterologia Kliniczna. 2010, 2(1), 1-9.

Jach M, Łoś R, Maj M, Malm A. Probiotyki - aspekty funkcjonalne i technologiczne. Post. Mikrobiol. 2013, 52(2) 161-170.

Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria. Report of a'Joint FAO/WHO Export Consultation, Cordoba, Argentina, 1-4.10.2001.

Forrsten SD, Sindelar CW, Ouwehand AC. Probiotics from an industrial perspective. Anaerobe. 2011, 17, 410-413. DOI: https://doi.org/10.1016/j.anaerobe.2011.04.014

Chen S, Zhao Q, Ferguson LR, Shu Q, Weir I, Garg S. Development of a novel probiotic delivery system based on microencapsulation with protectans. Appl. Microbiol. Biotechnol. 2012, 93, 1447-1457. DOI: https://doi.org/10.1007/s00253-011-3609-4

Burgain J, Gaiani C, Linder M, Scher J. Encapsulation of probiotic living cells: From laboratory scale to industrial applications. J. Food. Engineering. 2011, 104, 467-483. DOI: https://doi.org/10.1016/j.jfoodeng.2010.12.031

Libudzisz Z. Probiotics and prebiotics in fermented milks. Ped. Wsp. 2002, 4, 19-25.

Ewaschuck JB, Madsen KL. Mechanisms of probiotic effects: a review. Functional Food Rev. 2009, 1, 29-41.

Oelschalaeger TA. Mechanisms of probiotic action - A review. Int. J. Med. Microbiol. 2010, 300, 57-62. DOI: https://doi.org/10.1016/j.ijmm.2009.08.005

Collado MC, Meriluoto J, Salminem S. Adhesion and aggregation properties of probiotic and pathogen strains. Eur. Food Res. Technol. 2008, 226, 1065-1073. DOI: https://doi.org/10.1007/s00217-007-0632-x

Collado MC, Meriluoto J, Salminem S. In vitro analysis of probiotic strain combinations to inhibit pathogen adhesion to human intestinal mucus. Food Res. Int. 2007, 40, 629-639. DOI: https://doi.org/10.1016/j.foodres.2006.11.007

Stolarczyk A, Socha P, Socha J. Probiotics and prebiotics in prophylactic and therapeutic use in children. Terapia, 2002, 1, 116.

Grajek W, Sip A. Antagonistic activity of probiotics against pathogenic microorganisms. Zakazenia. 2006, 1, 49-54.

Lin SC, Lo YC, Wu H. Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signaling. Nature. 2010, 465, 885-890. DOI: https://doi.org/10.1038/nature09121

Shandilya UKr, Jadhav S, Panwar V, Kansal VK. Probiotics: Potent Immunomodulatory Tool Against Allergy. Probiotics & Antimicro. Prot. 2011, 3, 151-158. DOI: https://doi.org/10.1007/s12602-011-9077-4

Jijon H, Backer J, Diaz H, Yeung H, Thiel D, McKaigney C, De Simone C, Madsen K. DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology. 2004, 126, 1358-1373. DOI: https://doi.org/10.1053/j.gastro.2004.02.003

Matsumoto S, Hara T, Hori T, Mitsuyama K, Nagaoka M, Tomiyasu N, Suzuki A, Sata M. Probiotic Lactobacillus-induced improvement in murine chronic inflammatory bowel disease is associated with the down-regulation of pro-inflammatory cytokines in lamina propria mononuclear cells. Clin. Exp. Immunol. 2005, 140, 417-426. DOI: https://doi.org/10.1111/j.1365-2249.2005.02790.x

Zeuthen LH, Fink LN, Frokiaer H. Epithelial cells prime the immune response to an array of gutderived commensals towards a tolerogenic phenotype through distinct actions of thymic stromal lymphopoietin and transforming growth factor-beta. Immunology. 2008, 123, 197-208. DOI: https://doi.org/10.1111/j.1365-2567.2007.02687.x

Shida K, Nanno M. Probiotics and immunology: separating the wheat from the chaff. Trends Immunol. 2008, 29, 565-573. DOI: https://doi.org/10.1016/j.it.2008.07.011

de Vos WM. Systems solutions by lactic acid bacteria: from paradigms to practice. Microb. Cell Fact.,10 Suppl 1, S2. 2011, doi: 10.1186/1475-2859-10-S1-S2. DOI: https://doi.org/10.1186/1475-2859-10-S1-S2

Aggarwal J, Swami G, Kumar M. Probiotics and their Effects on Metabolic Diseases: An Update. J. Clin. Diagn. Res. 2013, 7, 173-177. DOI: https://doi.org/10.7860/JCDR/2012/5004.2701

Socha P, Stolarczyk M, Socha J. Wpływ probiotyków i prebiotyków na gospodarkę lipidową. Pediatr Współcz Gastroenterol Hepat Żyw Dziecka 2002, 04, 85-88.

Wickens K, Black PN, Stanley TV. Mitchell E, Fitzharris P, Tannock GW, Purdie G, Crane J. A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J. Allergy Clin. Immunol. 2008, 122(4), 788-94. DOI: https://doi.org/10.1016/j.jaci.2008.07.011

Kukowska A, Dziadziuszko R, Jassem J. Metody losowego przydziału leczenia w badaniach klinicznych. Onkologia w Praktyce Klinicznej. 2005, 1(3), 151-156.

Bartlett JG. Antibiotic-associated diarrhoea. N. Engl. J. Med. 2002, 346, 334-339. DOI: https://doi.org/10.1056/NEJMcp011603

Szajewska H, Ruszczyński M, Radzikowski A. Probiotics in the prevention of antibiotic-associated diarrhea in children: a meta-analysis of randomized controlled trials. J. Pediatr. 2006, 149, 367-372. DOI: https://doi.org/10.1016/j.jpeds.2006.04.053

Szajewska H, Mrukowicz J. Meta-analysis: non-pathogenic yeast Saccharomyces boulardii in the prevention of antibiotic- associated diarrhea. Aliment. Pharmacol. Ther. 2005, 22, 365-372. DOI: https://doi.org/10.1111/j.1365-2036.2005.02624.x

Hawrelak JA, Whitten DL, Myers SP. Is Lactobacillus rhamnosus GG effective in preventing the onset of antibioticassociated diarrhoea: a systematic review. Digestion. 2005, 72, 51-56. DOI: https://doi.org/10.1159/000087637

Guarino A, Albano F, Ashkenazi S. Gendrel D, Hoekstra JH, Shamir R, Szajewska H. European Society for Paediatric Gastroenterology, Hepatology and Nutrition/ /European Society for Paediatric Infectious Diseases Evidence–based Guidelines for the Management of Acute Gastroenteritis in children in Europe: Executive summary. J. Pediatr. Gastroenterol. Nutr. 2008, 46, 619-621. DOI: https://doi.org/10.1097/MPG.0b013e31816e219e

Van Niel C, Feudtner C, Garrison MM, Christakis DA. Lactobacillus therapy for acute infectious diarrhea in children: a metaanalysis. Pediatrics. 2002, 109, 678-684. DOI: https://doi.org/10.1542/peds.109.4.678

Huang JS, Bousvaros A, Lee JW, Diaz A, Davidson EJ. Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig. Dis. Sci. 2002, 47, 2625-2634. DOI: https://doi.org/10.1023/A:1020501202369

Szajewska H, Skórka A, Ruszczyński M. Gieruszczak-Białek D. Meta-analysis: Lactobacillus GG for treating acute diarrhoea in children. Aliment. Pharmacol. Ther. 2007, 25, 871-881. DOI: https://doi.org/10.1111/j.1365-2036.2007.03282.x

Szajewska H, Skórka A. Saccharomyces boulardii for treating acute gastroenteritis in children: updated meta-analysis of randomized controlled trials. Aliment. Pharmacol. Ther. 2009, 30, 960-961. DOI: https://doi.org/10.1111/j.1365-2036.2009.04113.x

McFarland LV. Meta-analysis of probiotics for the prevention of antibiotic associated diarrhea and the treatment of Clostridium difficile disease. Am. J. Gastroenterol. 2006, 101, 812-822. DOI: https://doi.org/10.1111/j.1572-0241.2006.00465.x

Dendukuri N, Costa V, McGregor M, Brophy JM. Probiotic therapy for the prevention and treatment of Clostridium difficileassociated diarrhea: a systematic review. CMAJ. 2005, 173, 167-170. DOI: https://doi.org/10.1503/cmaj.050350

D’Souza AL, Rajkumar C, Cooke J, Bulpitt Ch. Probiotics in prevention of antibiotic associated diarrhoea: Meta-analysis. BMJ. 2002, 324,1361. DOI: https://doi.org/10.1136/bmj.324.7350.1361

McFarland L.V., Dublin S. Meta-analysis of probiotics for the treatment of irritable bowel syndrome. World J. Gastroenterol. 2008, 14, 2650-2656. DOI: https://doi.org/10.3748/wjg.14.2650

Dendukuri N, Brophy J. Inappropriate use of meta-analysis to estimate efficacy of probiotics. Am. J. Gastroenterol. 2007, 102 (1), 201.

Tong JL., Ran ZH, Shen J, Zhang CX, Xiao SD. Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy. Aliment. Pharmacol. Ther. 2007, 25, 155-168. DOI: https://doi.org/10.1111/j.1365-2036.2006.03179.x

Moayyedi P., Ford A.C., Talley N.J. Cremonini F., Foxx-Orenstein A.E., Brandt L.J., Quigley E.M. The efficacy of probiotics in the therapy of irritable bowel syndrome: a systematic review. 2010, 59(3), 325-332. DOI: https://doi.org/10.1136/gut.2008.167270

Hoveyda N., Heneghan C., Mahtani K.R., Perera R., Roberts N., Glasziou P. A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome. BMC Gastroenterol. 2009, 9, 15. DOI: https://doi.org/10.1186/1471-230X-9-15

Huertas-Ceballos A., Logan S., Bennett C., Macarthur C. Psychosocial interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood. Cochrane Database of Systematic Reviews. 2008, 1, CD003014. DOI: https://doi.org/10.1002/14651858.CD003014.pub2

Chmielewska A, Szajewska H. Systematic review of randomised controlled trias: probiotics for functional constipation. World J. Gastroenterol. 2010, 16, 69-75.

Butterworth AD, Thomas AG, Akobeng AK. Probiotics for induction of remission in Crohn’s disease. Cochrane Database of Systematic Reviews. 2008, Issue 3. Art. No.: CD006634. DOI: 10.1002/14651858.CD006634.pub2. DOI: https://doi.org/10.1002/14651858.CD006634.pub2

Rahimi R, Nikfar S, Rahimi F., Elahi B., Derakhshani S., Vafaie M., Abdollahi M. A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn’s disease. Dig. Dis. Sci. 2008, 53, 2524-2531. DOI: https://doi.org/10.1007/s10620-007-0171-0

Lherm T, Monet C, Nougiere B, Soulier M, Larbi D, Le Gall C, Caen D, Malbrunot C. Seven cases of fungemia with Saccharomyces boulardii in critically ill patients. Intensive Care Med 2002, 28,797-801. DOI: https://doi.org/10.1007/s00134-002-1267-9

Braat H, de Jong EC, van den Brande JM, Kapsenberg ML, Peppelenbosch MP, van Tol EA, van Deventer SJ. Dichotomy between Lactobacillus rhamnosus and Klebsiella pneumoniae on dendritic cell phenotype and function. J Mol Med. 2004, 82,197-205. DOI: https://doi.org/10.1007/s00109-003-0509-9

Zocco M.A., dal Verme L.Z., Cremonini F., Piscaglia A.C.,Nista E.C., Candelli M., Novi M., Rigante D., Cazzato I.A., Ojetti V., Armuzzi A, Gasbarrini G, Gasbarrini A.: Efficacy of Lactobacillus GG in maintaining remission of ulcerative colitis. Aliment. Pharmacol. Ther. 2006, 23, 1567-1574. DOI: https://doi.org/10.1111/j.1365-2036.2006.02927.x

Boyle R.J., Robins-Browne R.M., Tang M.L.K. Probiotic use in clinical practice: what are the risks? Am. J. Clin. Nutr. 2006, 83, 1256-1264. DOI: https://doi.org/10.1093/ajcn/83.6.1256

Sun S., Yang K., He X., Tian J., Ma B., Jiang L. Probiotics in patients with severe acute pancreatitis: a meta-analysis. Langenbecks Arch. Surg. 2009, 394, 171-177. DOI: https://doi.org/10.1007/s00423-008-0379-2

Morrow LE, Kollef MH, Casale TB. Probiotic prophylaxis of ventilator-assosiated pneumonia- a blinded, randomized, controlled trial. Am J Respir Crit Care Med. 2010, 182,1058-1064. DOI: https://doi.org/10.1164/rccm.200912-1853OC

Aceti A, Gori D, Barone G, Callegari ML, Di Mauro A, Fantini MP, Indrio F, Maggio L, Meneghin F, Morelli L, Zuccotti G, Corvaglia L and on behalf of the Italian Society of Neonatology Probiotics for prevention of necrotizing enterocolitis in preterm infants: systematic review and meta-analysis Italian J of Pediatrics. 2015, 41,89. DOI: https://doi.org/10.1186/s13052-015-0199-2

Lolis N, Veldekis D, Moraitou H, Kanavaki S, Velegraki A, Triandafyllidis C, Tasioudis C, Pefanis A, Pneumatikos I. Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofungin. Crit Care. 2008, 12, 414. DOI: https://doi.org/10.1186/cc6843

Santino I, Alari A, Bono S, Teti E, Marangi M, Bernardini A, Magrini L, Di Somma S, Teggi A. Saccharomyces cerevisiae fungemia, a possible consequence of the treatment of Clostridium difficile colitis with a probioticum. Int J Immunopathol Pharmacol. 2014, 27,143-146. DOI: https://doi.org/10.1177/039463201402700120

Vahabnezhad E, Mochon AB, Wozniak LJ, Ziring DA Lactobacillus bacteremia associated with probiotic use in a pediatric patient with ulcerative colitis. J Clin Gastroenterol. 2013, 47, 437-439. DOI: https://doi.org/10.1097/MCG.0b013e318279abf0

Conen A, Zimmerer S, Frei R, Trampuz A, Battegay M, Elzi L. A pain in the neck: probiotics for ulcerative colitis. Ann Intern Med. 2009, 151, 895-897. DOI: https://doi.org/10.7326/0003-4819-151-12-200912150-00020

Ku W. Probiotics provoked D-lactic acidosis in short bowel syndrome: case report and literature review. HK J Paediatr. 2006, 11, 246-254.

Besselink MG, van Santvoort HC, Buskens E, Boermeester MA, van Goor H, Timmerman HM, Nieuwenhuijs VB, Bollen TL, van Ramshorst B, Witteman BJ, Rosman C, Ploeg RJ, Brink MA, Schaapherder AF, Dejong CH, Wahab PJ, van Laarhoven CJ, van der Harst E, van Eijck CH, Cuesta MA, Akkermans LM, Gooszen HG; Dutch Acute Pancreatitis Study Group. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2008, 371,651-659. DOI: https://doi.org/10.1016/S0140-6736(08)60207-X

Vaarala O. Immunological effects of probiotics with special reference to lactobacilli. Clin Exp Allergy. 2003, 33,1634-1640. DOI: https://doi.org/10.1111/j.1365-2222.2003.01835.x

Drakes M, Blanchard T, Czinn S Bacterial probiotic modulation of dendritic cells. Infect Immun. 2004, 72, 3299-3309. DOI: https://doi.org/10.1128/IAI.72.6.3299-3309.2004

Marteau P.R. Probiotics in clinical conditions. Clin. Rev. Allergy Immunol. 2002, 22, 255-273. DOI: https://doi.org/10.1007/s12016-002-0011-0

Cannon J.P., Lee T.A., Bolanos J.T., Danziger L.H.: Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur. J. Clin. Microbiol. Infect. Dis. 2005, 24, 31-40. DOI: https://doi.org/10.1007/s10096-004-1253-y

Kubiszewska I, Januszewska M, Rybka J, Gackowska L. Bakterie kwasu mlekowego i zdrowie: czy probiotyki są bezpieczne dla człowieka? Postepy Hig Med Dosw (online). 2014, 68, 1325-1334. DOI: https://doi.org/10.5604/17322693.1129120

Floch M.H., Walker W.A., Guandalini S., Hibberd P., Gorbach S., Surawicz C., Sanders M.E., Garcia-Tsao G., Quigley E.M., Isolauri E., Fedorak R.N., Dieleman L.A. Recommendations for probiotic use - J. Clin. Gastroenterol. 2008, 42 (supl. 2), S104-108. DOI: https://doi.org/10.1097/MCG.0b013e31816b903f

Fric P. Probiotics and prebiotics - renaissance of a therapeutic principle. CEJ Med. 2007, 2, 237-270. DOI: https://doi.org/10.2478/s11536-007-0031-5

Kligler B., Hanaway P., Cohrssen A. Probiotics in children. Pediatr. Clin. North Am. 2007, 54, 949-967. DOI: https://doi.org/10.1016/j.pcl.2007.10.002

Libudzisz Z.: Human intestinal microflora and probiotics. Zakażenia, 2004, 6, 47-51.

Shanahan F.: Probiotics in perspective. Gastroenterology, 2010, 139, 1808-1812. DOI: https://doi.org/10.1053/j.gastro.2010.10.025

Sleator R.D., Hill C.: New frontiers in probiotic research. Lett. Appl. Microbiol. 2008, 46, 143-147. DOI: https://doi.org/10.1111/j.1472-765X.2007.02293.x

Szewczyk, K., Wzrost Listeria monocytogenes a warunki środowiskowe, Przemysł spożywczy 11/2015 (69), 12-15. DOI: https://doi.org/10.15199/65.2015.11.4

Sheehan V.M., Sleator R.D., Fitzgerald G.F., Hill C.: Heterologous expression of BetL, a betaine uptake system, enhances the stress tolerance of Lactobacillus salivarius UCC118. Appl. Environ. Microbiol. 2006, 72, 2170. DOI: https://doi.org/10.1128/AEM.72.3.2170-2177.2006

Corcoran BM, Ross RP, Fitzgerald GF, Dockery P, Santon C. Enhanced survival of GroESL-overproducing Lactobacillus paracasei NFBC 338 under stressful conditions induced by drying. Appl. Environ. Microb. 2006, 72, 5104-5107. DOI: https://doi.org/10.1128/AEM.02626-05

Paton A.W., Morona R., Paton J.C.: Receptor-mimic probiotics: potential therapeutics for bacterial toxin-mediated enteric diseases. Expert Rev. Gastroenterol. Hepatol. 2010, 4, 253-255. DOI: https://doi.org/10.1586/egh.10.30

Guimarães V.D., Gabriel J.E., Lefèvre F., Cabanes D., Gruss'A., Cossart P.: Internalin-expressing Lactococcus lactis is able to invade small intestine of guinea pigs and deliver DNA into mammalian epithelial cells. Microbes Infect. 2005, 7, 836-44. DOI: https://doi.org/10.1016/j.micinf.2005.02.012

Toczek K, Glibowski P. Bakterie probiotyczne w żywności nowe kierunki stosowania. Przemysł Spożywczy. 2015, 69, 42-45.

Osęka G. Oświadczenia zdrowotne dotyczące probiotyków. Przemysł Spożywczy. 2014, 68(12), 28-29.

Bulwarska M., Florowska A.: Lody z dodatkami prozdrowotnymi. Przemysł spożywczy. 2011, 65, 11, 22-24.

Szydłowska A., Kołożyn-Krajewska D. Zastosowanie bakterii potencjalnie probiotycznych do fermentacji przecieru z dyni. Żywność. Nauka. Technologia. Jakość. 2010, 73, 6, 109 -119.

Trząskowska M. Probiotyki w produktach pochodzenia roślinnego. Żywność. Nauka.Technologia. Jakość. 2013, 89, 4, 5-20.

Arihara K. Strategies for designing novel functional meat products. Meat Science. 2006 74, 1, 219-229. DOI: https://doi.org/10.1016/j.meatsci.2006.04.028

Altamirano-Fortoul R., Moreno-Terrazas R., Quezada-Gallo A., Rosell C.: Viability ofsome probioticcoatings in bread and its effect on the crust mechanical properties. Food Hydrocolloids. 2012, 1, 29, 166-174. DOI: https://doi.org/10.1016/j.foodhyd.2012.02.015

Steinka I. Wybrane aspekty stosowania probiotyków. Ann. Acad. Med. Gedan. 2011, 41, 97-108.

Zielińska D, Ołdak A, Rzepkowska A, Kołożyn-Krajewska D. Metody identyfikacji probiotyków w żywności. Wyzwania i problemy. Przemysł Spożywczy. 2017, 1, 71. DOI: https://doi.org/10.15199/65.2017.2.5

Guidance on the scientific requirements for health claims related to the immune system, the gastrointestinal tract and defence against pathogenic microorganisms EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA) PUBLISHED: 18 January 2016 doi:10.2903/j.efsa.2016.4369. DOI: https://doi.org/10.2903/j.efsa.2016.4369

Dominika Winiarz

dominikawiniarz41@gmail.com

Affiliation:

Studenckie Koło Naukowe „Bromatos” przy Zakładzie Bromatologii, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej, Warszawski Uniwersytet Medyczny, ul. Banacha 1, 02-097 Warszawa Poland

Kamila Domańska

Affiliation:

Kinga Paluch

Affiliation:

Dorota Dorota Skrajnowska

Affiliation:

Zakład Bromatologii, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej Warszawski Uniwersytet Medyczny, ul. Banacha 1, 02-097 Warszawa Poland